medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Number 1

<< Back Next >>

Ann Hepatol 2005; 4 (1)

Hepatitis G virus RNA positivity among the voluntary blood donors: a summary

Wiwanitkit V

Language: English
References: 38
Page: 43-46
PDF size: 45.35 Kb.


Text Extraction

Hepatitis virus infection is an increasing problem. Millions of humans all over the world are infected. Viral hepatitis is accepted as a significant public health problem with several life altering complications. Recently, new viruses have been identified for their association with hepatitis. Hepatitis G virus (HGV) is a single stranded RNA virus which represents a newly discovered virus belonging to the flavivirus family. Epidemiological data indicate that the virus is transmitted via blood/blood products, sexually and vertically from infected mothers to children. There are some previous reports on the prevalence of HGV infection among the blood/blood products. The purpose of this study is to summarize the prevalence of HGV infection, defined as HGV RNA positivity, among the voluntary blood donors in the previous reports. Due to this study, there have been at least 30 reports. Of 13,610 documented voluntary donors, there are 649 cases with HGV RNA positivity. The summative percentage for HGV RNA positivity is 4.8%: 4.5% in Caucasian, 3.4 % in Asian and 17.2% in Negroid. There is no significant association between ethnicity of donors and prevalence of HGV RNA positivity (p › 0.05). The HGV infection seems to distribute in all ethnicities all over the world, implying the global importance of this hepatitis virus infection. Screening for HGV RNA might be an important test in blood bank process in the future.


REFERENCES

  1. Sehgal R, Sharma A. Hepatitis G virus (HGV): current perspectives. Indian J Pathol Microbiol 2002; 45: 123-128.

  2. Stapleton JT. GB virus type C/Hepatitis G virus. Semin Liver Dis 2003; 23: 137-148.

  3. Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schluter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-1323.

  4. Orito E, Mizokami M, Nakano T, Wu RR, Cao K, Ohba K, Ueda R, Mukaide M, Hikiji K, Matsumoto Y, Iino S. GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. Virus Res 1996; 46: 89-93.

  5. Hwang SJ, Chu CW, Lu RH, Lan KH, Wu JC, Wang YJ, Chang FY, Lee SD. Seroprevalence of GB virus C/hepatitis G virus-RNA and anti-envelope antibody in high-risk populations in Taiwan. J Gastroenterol Hepatol 2000; 15: 1171-1175.

  6. Jongerius J, Boland G, van der Poel C, Rasch M, Italiaander E, van der Reijden J, Friedman P, Cockerill J, van Leeuwen E, van Hattum J. GB virus type C viremia and envelope antibodies among population subsets in The Netherlands. Vox Sang 1999; 76: 81-84.

  7. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-320.

  8. Levi JE, Contri DG, Lima LP, Takaoka DT, Garrini RH, Santos W, Fachini R, Wendel S. High prevalence of GB virus C/hepatitis G virus RNA among Brazilian blood donors. Rev Inst Med Trop Sao Paulo 2003; 45: 75-78.

  9. Jeon MJ, Shin JH, Suh SP, Lim YC, Ryang DW. TT virus and hepatitis G virus infections in Korean blood donors and patients with chronic liver disease. World J Gastroenterol 2003; 9: 741-744.

  10. Oliveira LA, Martins RM, Carneiro MA, Teles SA, Silva SA, Cardoso DD, Lampe E, Yoshida CF. Prevalence and genotypes of GB virus C/hepatitis G virus among blood donors in Central Brazil. Mem Inst Oswaldo Cruz 2002; 97: 953-957.

  11. Yan J, Chen LL, Luo YH, Mao YF, He M. High frequencies of HGV and TTV infections in blood donors in Hangzhou. World J Gastroenterol 2001; 7: 637-641.

  12. Yu ML, Chuang WL, Wang LY, Dai CY, Chiou SS, Sung MH, Chang CS, Chen SC, Wang CS, Chang TT, Chang WY. Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan. J Gastroenterol Hepatol 2000; 15: 1404-1410.

  13. Nordbo SA, Krokstad S, Winge P, Skjeldestad FE, Dalen AB. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors. J Clin Microbiol 2000; 38: 2584-2590.

  14. Al-Ahdal MN, Rezeig MA, Kessie G, Chaudhry F, Al-Shammary FJ. GB virus C/hepatitis G virus infection in Saudi Arabian blood donors and patients with cryptogenic hepatitis. Arch Virol 2000; 145: 73-84.

  15. Brojer E, Grabarczyk P, Kryczka W, Kucharski W, Kubicka J, Zupanska B. Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis. J Viral Hepat 1999; 6: 471-475.

  16. Love A, Stanzeit B, Gudmundsson S, Widell A. Hepatitis G virus infections in Iceland. J Viral Hepat 1999; 6: 255-260.

  17. Oubina JR, Mathet V, Feld M, Della Latta MP, Ferrario D, Verdun R, Libonatti O, Fernandez J, Carballal G, Sanchez DO, Quarleri JF. Genetic diversity of GBV-C/HGV strains among HIV infected-IVDU and blood donors from Buenos Aires, Argentina. Virus Res 1999; 65: 121-129.

  18. Konomi N, Miyoshi C, La Fuente Zerain C, Li TC, Arakawa Y, Abe K. Epidemiology of hepatitis B, C, E, and G virus infections and molecular analysis of hepatitis G virus isolates in Bolivia. J Clin Microbiol 1999; 37: 3291-3295.

  19. Cesaire R, Martial J, Maier H, Kerob-Bauchet B, Bera O, Duchaud E, Brebion A, Pierre-Louis S. Infection with GB virus C/hepatitis G virus among blood donors and hemophiliacs in Martinique, a Caribbean island. J Med Virol 1999; 59: 160-163.

  20. Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol 1999; 59: 38-44.

  21. El-Zayadi AR, Abe K, Selim O, Naito H, Hess G, Ahdy A. Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. J Virol Methods 1999; 80: 53-58.

  22. Sauleda S, Esteban JI, Hernandez JM, Reesink H, Castella D, Quer J, Hess G, Esteban R, Guardia J. Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood. Transfusion 1999; 39: 633-638.

  23. Cantaloube JF, Gallian P, Biagini P, Attoui H, Escher J, Zappitelli JP, Delord Y, de Micco P, de Lamballerie X. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France. Transfusion 1999; 39: 95-102.

  24. Minton J, Iqbal A, Eskiturk A, Irving W, Davies J. Hepatitis G virus infection in lymphoma and in blood donors. J Clin Pathol 1998; 51: 676-678.

  25. Blair CS, Davidson F, Lycett C, McDonald DM, Haydon GH, Yap PL, Hayes PC, Simmonds P, Gillon J. Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis 1998; 178: 1779-1782.

  26. Hyland CA, Mison L, Solomon N, Cockerill J, Wang L, Hunt J, Selvey LA, Faoagali J, Cooksley WG, Young IF, Trowbridge R, Borthwick I, Gowans EJ. Exposure to GB virus type C or hepatitis G virus in selected Australian adult and children populations. Transfusion 1998; 38: 821-827.

  27. Wang JT, Chen PJ, Liu DP, Sheu JC, Wang TH, Chen DS. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan. Transfusion 1998; 38: 290-295.

  28. Lampe E, de Oliveira JM, Pereira JL, Saback FL, Yoshida CF, Niel C. Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors. Clin Diagn Virol 1998; 9: 1-7.

  29. Shev S, Bjorkman P, Norkrans G, Foberg U, Fryden A, Lindh G, Lindholm A, Weiland O, Widell A. GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors. J Med Virol 1998; 54: 75-79.

  30. Prati D, Capelli C, Zanella A, Bosoni P, De Mattei C, Mozzi F, Donato MF, Colombo M, Milani S, Sirchia G. Asymptomatic hepatitis G virus infection in blood donors. Transfusion 1997; 37: 1200-1204.

  31. Loiseau P, Mariotti M, Corbi C, Ravera N, Girot R, Thauvin M, Portelette E, Mariette X, Roudot-Thoraval F, Benbunan M, Lefrere JJ. Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion 1997; 37: 645-650.

  32. Wu RR, Mizokami M, Cao K, Nakano T, Ge XM, Wang SS, Orito E, Ohba K, Mukaide M, Hikiji K, Lau JY, Iino S. GB virus C/hepatitis G virus infection in southern China. J Infect Dis 1997; 175: 168-171.

  33. Hitzler WE, Runkel S. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components. Clin Lab 2004; 50: 25-31.

  34. Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis 2001; 33: 572-580.

  35. Allain JP, Thomas I, Sauleda S. Nucleic acid testing for emerging viral infections. Transfus Med 2002;12:275-283

  36. Allain JP Emerging viral infections relevant to transfusion medicine. Blood Rev 2000; 14: 173-181.

  37. Herve P. Transfusion safety: emergent or hypothetical risks. Transfus Clin Biol 2000; 7: 30-38.

  38. Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35: S86-S91.




2020     |     www.medigraphic.com